GlaxoSmithKline PLC
15 January 2001
Director's Interests
I give below details of a change in the interests in ADRs of GlaxoSmithKline
plc (each ADR represents two Ordinary Shares) in respect of the undermentioned
Director arising from the purchase of ADRs on 11th January 2001 through the
monthly investment element of the US Global BuyDirect Plan administered by The
Bank of New York, which Mr McArthur entered on 4th May 1997:-
Mr J H McArthur Beneficial interest in 92.6357 ADRs purchased at a price of
US$ 53.55 per ADR.
Mr McArthur and the Company were advised of this information on 12th January
2001.
S M Bicknell
15th January 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.